Chun Gong
BQ323636.1, a novel splice variant to NCOR2, as a predictor for tamoxifen resistant breast cancer
Gong, Chun; Man, Ellen P.S.; Tsoi, Ho; Lee, Terence K.W.; Paul, Lee; Mak, Sai-Ting; Wong, Lai-Shan; Luk, Mei-Yee; Rakha, Emad A.; Green, Andrew R.; Ellis, Ian O.; Lam, Eric W.F.; Cheung, Kwok-Leung; Khoo, Ui-Soon
Authors
Ellen P.S. Man
Ho Tsoi
Terence K.W. Lee
Lee Paul
Sai-Ting Mak
Lai-Shan Wong
Mei-Yee Luk
EMAD RAKHA Emad.Rakha@nottingham.ac.uk
Professor of Breast Cancer Pathology
ANDREW GREEN ANDREW.GREEN@NOTTINGHAM.AC.UK
Associate Professor
Professor IAN ELLIS IAN.ELLIS@NOTTINGHAM.AC.UK
Professor of Cancer Pathology
Eric W.F. Lam
Professor KWOK_LEUNG CHEUNG KWOK_LEUNG.CHEUNG@NOTTINGHAM.AC.UK
Deputy Head of Education & Director of The Bmbs Medicine Programmes
Ui-Soon Khoo
Abstract
Purpose: Adjuvant tamoxifen treatment revolutionized the management of estrogen receptor (ER) positive breast cancers to prevent cancer recurrence; however drug resistance compromises its clinical efficacy. The mechanisms underlying tamoxifen resistance are not fully understood and no robust biomarker is available to reliably predict those who will be resistant. Here we study BQ323636.1, a novel splice variant of the NCOR2 gene and evaluate its efficacy in predicting tamoxifen resistance in breast cancer patients.
Experimental Design: A monoclonal anti-BQ323636.1 antibody that specifically recognizes the unique epitope of this splice variant was generated for in vitro mechanistic studies and for in vivo analysis by immunohistochemistry on tissue microarrays of two independent cohorts of 358 patients with more than 10 years clinical follow-up data, who had ER-positive primary breast cancer and received adjuvant tamoxifen treatment. Orthotopic mouse model was also used.
Results: Overexpression of BQ323636.1 conferred resistance to tamoxifen in both in vitro and in orthotopic mouse model. Mechanistically, co-immunoprecipitation showed BQ could bind to NCOR2 and inhibit the formation of co-repressor complex for the suppression of ER signaling. Nuclear BQ overexpression in patients samples was significantly associated with tamoxifen resistance (p= 1.79 x 10-6, sensitivity 52.9%, specificity 72.0%). In tamoxifen-treated patients, nuclear BQ overexpression was significantly correlated with cancer metastasis and disease relapse. Nuclear BQ was also significantly associated with poorer overall survival (p=1.13 x 10-4) and disease-specific survival (p=4.02 x 10-5).
Conclusions: These findings demonstrate that BQ can be a reliable biomarker to predict tamoxifen resistance in ER-positive breast cancer patients.
Citation
Gong, C., Man, E. P., Tsoi, H., Lee, T. K., Paul, L., Mak, S., …Khoo, U. (2018). BQ323636.1, a novel splice variant to NCOR2, as a predictor for tamoxifen resistant breast cancer. Clinical Cancer Research, 24(15), 3681-3691. https://doi.org/10.1158/1078-0432.CCR-17-2259
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 23, 2018 |
Online Publication Date | Feb 2, 2018 |
Publication Date | Aug 28, 2018 |
Deposit Date | Jan 4, 2018 |
Publicly Available Date | Feb 3, 2019 |
Journal | Clinical Cancer Research |
Print ISSN | 1078-0432 |
Electronic ISSN | 1557-3265 |
Publisher | American Association for Cancer Research |
Peer Reviewed | Peer Reviewed |
Volume | 24 |
Issue | 15 |
Pages | 3681-3691 |
DOI | https://doi.org/10.1158/1078-0432.CCR-17-2259 |
Keywords | NCOR2/SMRT; BQ323636.1; Tamoxifen-resistance; breast cancer |
Public URL | https://nottingham-repository.worktribe.com/output/908461 |
Publisher URL | http://clincancerres.aacrjournals.org/content/early/2018/02/02/1078-0432.CCR-17-2259 |
Files
187315_1_merged_1512555844.pdf
(1.2 Mb)
PDF
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: digital-library-support@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search